Stem cell quality in India is tested through a structured set of laboratory assays covering identity, viability, sterility, purity, and potency. Every clinical-grade stem cell product must pass these tests before it goes anywhere near a patient. The work happens inside GMP-certified facilities, regulated under the National Guidelines for Stem Cell Research and supervised by ICMR, DBT, and CDSCO. Indian labs are aligned with global standards, the same protocols clinics in the US, EU, and Japan run on, applied to every cell type used in stem cell therapy in India.
According to a specialist at MedTravellers, Renowned Specialist in Stem Cell Therapy in India
“Quality testing is non-negotiable in regenerative medicine. Every batch of cells we work with goes through the full panel, identity, sterility, viability, the lot. We do not infuse anything that has not cleared every single one. That discipline is what separates a credible clinic from a questionable one.”
The framework that governs it:
The regulatory framework behind Indian stem cell labs
Stem cell labs in India do not operate in a vacuum. The work is governed by a layered framework that pulls in multiple national bodies.
4 regulatory layers shape every approved lab:
- ICMR and DBT: the National Guidelines for Stem Cell Research, updated in 2025, set the ethical and scientific baseline for all stem cell work in India
- CDSCO: clinical-grade cells must be processed in CDSCO-certified GMP and GLP facilities under Schedule M of the Drugs and Cosmetics Rules
- NABL accreditation: any lab processing stem cells for human use must hold National Accreditation Board for Testing and Calibration Laboratories certification
- Institutional oversight: every clinical use requires approval from the Institutional Committee for Stem Cell Research and the Institutional Ethics Committee
This is the floor, not the ceiling. The labs working with mesenchymal stem cells and umbilical cord-derived cells typically run well above the minimum compliance line.
What actually gets tested:
Core quality tests every stem cell batch goes through
-
Once stem cells are isolated and expanded, every batch runs through a defined panel of laboratory tests. The aim is straightforward: confirm the cells are what they claim to be, that they are alive, free of contamination, and capable of doing the clinical job they are meant to.
The core test panel includes:
- Identity testing: flow cytometry with surface marker analysis confirms the cell type. For MSCs, the standard panel includes CD73, CD90, and CD105 positivity, with CD34 and CD45 negativity
- Viability assay: trypan blue exclusion or 7-AAD staining confirms the percentage of living cells. Clinical-grade product typically requires above 80 percent viability at release
- Sterility testing: culture-based and rapid molecular methods rule out bacterial, fungal, and mycoplasma contamination
- Potency assay: functional tests that confirm the cells can perform their intended biological action, including differentiation capacity and immunomodulation response
A failed result on any one of these closes the batch. There is no workaround, the cells are not released for clinical use.
Not sure if stem cell therapy is right for you?
Connect with our medical experts today and get a personalized treatment plan tailored to your condition.
Why patients choose us:
Why choose MedTravellers ?
MedTravellers works only with GMP-certified Indian labs that follow the full quality testing panel mandated by ICMR and CDSCO. Every cell batch used in our treatment protocols carries documented results across identity, viability, sterility, and potency. Patients from over 40 countries receive transparent information on the cells being used and the quality controls behind them, before any procedure is scheduled.
FAQ
GMP, or Good Manufacturing Practice, is a regulatory standard ensuring cells are processed in controlled, sterile, traceable conditions. Indian GMP labs follow Schedule M of the Drugs and Cosmetics Rules.
The full quality panel typically takes 7 to 14 days, depending on the cell type and the depth of testing required for that batch.
The batch is rejected and never released for clinical use. A new isolation and expansion cycle is started from a fresh source, with full testing repeated.
Yes. CDSCO-certified GMP labs in India follow the same ISCT, ISHAGE, and ICH guidelines used in the US, EU, and Japan. The core test panels are identical.
Reference Links
- National Guidelines for Stem Cell Research, ICMR-DBT — the foundational regulatory document for Indian stem cell labs https://www.icmr.gov.in/guidelines
- PMC, Indian Regulatory Framework for Stem Cell Therapies — analysis of CDSCO, GMP, and GLP requirements in India https://pmc.ncbi.nlm.nih.gov/articles/PMC12632954/